INNODIA HARVEST Final Annual Meeting - LIVESTREAM (April 10, 2024)
The INNODIA and INNODIA HARVEST Projects have come to an end.
To celebrate the outcomes and commemorate everyone who participated in this exiting journey
the INNODIA and INNODIA HARVEST Final Annual Meeting will take place on 10th and 11th April 2024, in Leuven, Belgium.
Although the in-person meeting is closed to INNODIA members only,
a livestream will be available on DAY1 of the meeting (Wednesday, 10th April) for everyone who is interested!
You are welcome to join via this link: https://livestream.kuleuven.be/?pin=826359
You can download an .ics file here, so you can add the date to your calendar:
INNODIA and INNODIA HARVEST Final Annual Meeting - DAY 1 PROGRAM:
13:00 – 13:30
Welcome – Looking back to look forward: the story of the INNODIA projects
Chantal Mathieu (KU Leuven) and Mark Peakman (Sanofi)
13:30 – 14:50
Themed session 1: How large consortia make us move forward!
Chairs: Piero Marchetti
13:30 – 13:45
The IHI perspective on INNODIA projects
Klelia Salpea (IHI)
13:45 – 14:00
Do large consortia help us move forward? – a view from the Academic and Industry site
Mark Peakman (Sanofi)
14:00 – 14:15
Being part of a large consortium: view from a young scientist
Teresa Rodriguez (HMGU)
14:15 – 14:30
Being part of a large consortium: view from a foundation
Gina Agiostratidou (HCT)
14:30 - 14:50
Victories and hurdles in INNODIA and INNODIA Harvest
Chantal Mathieu (KU Leuven)
14:50 – 15:30
BREAK
15:30 – 17:30
Themed session 2: How the INNODIA projects designed, performed and helped change the face of clinical trials in T1D
Chairs: Emanuele Bosi
15:30 – 16:00
Roundtable (all trial sponsors): INNODIA & INNODIA Harvest clinical trials: Short Update on Status
Chaired by Thomas Danne (HKA)
16:00 – 16:30
Roundtable (all trial sponsors): Learnings from INNODIA & INNODIA Harvest trials: the view of trial sponsors
Chaired by Esther Latres (JDRF)
16:30 – 17:00
Learnings from the clinical trials in INNODIA and INNODIA Harvest: towards new trial designs
Colin Dayan (CU)
17:00 – 17:30
Roundtable (all PAC members that are present): Learnings from the clinical trials in INNODIA: the impact of the PAC in trials and other activities
Chaired by Jeannette Soderberg (Novo)
Archive
:: 16. April 2020
More time to reflect will lead to better insights
As a PhD student, I mainly work from home nowadays due to the measurements taken by the government because of the coronavirus crisis.
:: 14. April
How does someone with three hats experience COVID-19?
Markku Saraheimo is a healthcare professional, a patient and the father of a patient.
:: 06. April
Message from the PAC chair - Dr. Olivier Arnaud
Quite a strange period in our lives, not only from a personal point of view, but also worldwide, which leads us all to think about what is important.
:: 03. April 2020
PAC member turns to her sewing machine
COVID-19 … What was considered at the beginning as "flu", quickly turned into an extremely contagious virus.
:: 01. April 2020
No greater risk, if well managed!
In these days where COVID-19 fills the headlines, people with chronic diseases, such as T1D, have to be particularly careful to follow the guidance from the health authorities.
:: 27. March 2020
Worth fighting for!
Talking about the Corona virus makes me a bit restless.
:: 26. March 2020
Find your local sources about COVID-19
Some useful links regarding COVID-19
:: 25. March 2020
Corona virus from a scientist perspective
I work on basic research of type 1 diabetes in Dresden, Germany. Our university decided to close down all research labs to prevent employees from getting sick.
:: 23. March 2020
Message from Dr. C. Mathieu about COVID-19
A Message to the current situation
:: 23. March 2020
COVID-19! Say what?
We [Type one diabetes patients] hear it all the time. “Your immune system is not as strong as in a healthy person”, ”You are more vulnerable to pick up infections”, “you’re more likely to catch this”, “you have an increased risk to get that” …
:: 18. March 2020
INNODIA in times of COVID-19
As of today INNODIA decided to pause the clinical study until May 1st.
By using this website, you agree to the use of cookies. For more information visit: Privacy policy